Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Cessation Therapeutics Novel CSX-1004 Receives FDA Fast Track Designation for Preventing Fentanyl Overdose
Cessation Therapeutics, a clinical-stage biotechnology company focused on advancing biologics targeting substances of abuse, announced today that the U.S. Food and Drug Administration...
University of Minnesota Medical School Team Discovers Breakthrough Drug for Rare Kidney Disorder
The University of Minnesota Medical School has spearheaded recent research that unveils promising prospects in the treatment of Focal Segmental Glomerulosclerosis...
A Groundbreaking Revelation - Inhibiting P-glycoprotein (P-GP) Targets Dormant Tumor Cells After Chemotherapy
A research team at the Medical University of Vienna has made a significant breakthrough in addressing dormant tumor cells that can survive chemotherapy. Their discovery revolves around the inhibition of a specific protein known as P-glycoprotein...
Birmingham Platelet Group Unveils Pioneering Nanobody Technology Breakthrough
Researchers from the University of Birmingham have introduced a groundbreaking development in the realm of thrombosis research. They have pioneered a novel class of antibody...
Amicus Therapeutics Launches Groundbreaking Pompe Disease Treatment
Amicus Therapeutics, has secured FDA approval for an innovative two-part therapy known as Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg capsules....
Servier's TIBSOVO® (Ivosidenib Tablets) Granted FDA Acceptance and Priority Review for Treating IDH1-Mutated Relapsed or Refractory Myelodysplastic Syndrome
Servier, a renowned player in the field of oncology dedicated to advancing patient care, has made a significant announcement....
Zai Lab Secures Breakthrough Therapy Designation for Efgartigimod Alfa Injection in CIDP Patients
Zai Lab Limited has recently secured Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for their efgartigimod alfa injection...
FDA Grants Breakthrough Therapy Designation to INOVIO's INO-3107 for Recurrent Respiratory Papillomatosis
INOVIO, a biotechnology firm specializing in the development and commercialization of DNA-based therapeutics for HPV-related diseases, cancer, and infectious ailments, has recently achieved a significant milestone....
ENHERTU® Secures Dual Breakthrough Therapy Designations from US Regulatory Authorities
ENHERTU® has recently been granted two additional Breakthrough Therapy Designations (BTDs) by regulatory authorities in the United States. These designations pertain to the treatment of specific groups of patients facing challenging medical circumstances...
Zai Lab's Repotrectinib Earns Breakthrough Designation in China for NTRK-Positive Tumors
Zai Lab Limited has announced the granting of Breakthrough Therapy Designation by the Center for Drug Evaluation (CDE) under the National Medical Products Administration (NMPA). This designation applies to the investigational drug repotrectinib, which is intended for the treatment of advanced solid tumors characterized by NTRK gene fusions....
